Fragile X Associated Primary Ovarian Insufficiency test

Test description

The testing of women experiencing either POI or early menopause-like symptoms, for fragile X, is therefore recommended. Female fragile X premutation carriers may suffer from fragile X associated primary ovarian insufficiency (FXPOI), which can lead to infertility and early menopause in some female carriers. Common symptoms of POI include absent or irregular periods and infertility.

Test information

Test name

Fragile X

Clinical indication

For the investigation of intellectual disability, developmental delay, autism, late-onset ataxia, neurodegeneration or premature ovarian failure.
Risk assessment of a relative of a person with an FMR1 mutation

Gene(s)

FMR1

Method

PCR Fragment Sizing

Turn around time

2 weeks

Medicare eligibility

73300 – criteria apply

Price

If not MBS eligible, please contact 1800 822 999 for pricing details

Test request form

Standard pathology request form

Sample type

Blood

Collection type

6mL EDTA tube

Special instructions

None